Sinusitis, enlarged nasal turbinates, tumors, infections, hearing disorders, allergic conditions, facial fractures and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches and, in many cases, flexible catheters as opposed to instruments having rigid shafts. Various diagnostic procedures and devices are used to perform imaging studies, mucus flow studies, air/gas flow studies, anatomic dimension studies, endoscopic studies and transillumination studies. Access and occluder devices may be used to establish fluid tight seals in the anterior or posterior nasal cavities/nasopharynx and to facilitate insertion of working devices (e.g., scopes, guidewires, catheters, tissue cutting or remodeling devices, electrosurgical devices, energy emitting devices, devices for injecting diagnostic or therapeutic agents, devices for implanting devices such as stents, substance eluting devices, substance delivery implants, etc.

A blood coagulant assembly having a blood coagulant device adapted to be placed into a nostril of a patient suffering from a nose bleed. The blood coagulant device being initially placed within a blood coagulant device container which has a top section and a bottom section each secured to the other in a releasable manner. The blood coagulant device being mounted in a fixed position within the blood coagulant device container prior to removal of the blood coagulant device for insertion into a patient's nose that is bleeding. The blood coagulant device having a handle lower section and a handle upper section with a through opening passing through both the lower and upper handle sections. A blood coagulant material is secured onto an outer surface of the blood coagulant device to be placed against an inner surface of the nostril of a patient that is experiencing a bleeding nose for the purpose of stopping the nose from bleeding.

Sinusitis, enlarged nasal turbinates, tumors, infections, hearing disorders, allergic conditions, facial fractures and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches and, in many cases, flexible catheters as opposed to instruments having rigid shafts. Various diagnostic procedures and devices are used to perform imaging studies, mucus flow studies, air/gas flow studies, anatomic dimension studies, endoscopic studies and transillumination studies. Access and occluder devices may be used to establish fluid tight seals in the anterior or posterior nasal cavities/nasopharynx and to facilitate insertion of working devices (e.g., scopes, guidewires, catheters, tissue cutting or remodeling devices, electrosurgical devices, energy emitting devices, devices for injecting diagnostic or therapeutic agents, devices for implanting devices such as stents, substance eluting devices, substance delivery implants, etc.

Effective treatments of pain and/or inflammation are provided. Through the administration of a porous biodegradable drug depot film, patch, strip or sponge being implantable within a nasal or sinus cavity and having pores sized to prevent the depot from functioning as a scaffold for tissue growth, one can reduce, prevent or treat pain and/or inflammation and prevent cells from infiltrating the drug depot and laying down scaffolding cells.

An implantable article comprising a dissolvable sponge derived from the mixture of chitosan, a first polysaccharide and a second polysaccharides. The polysaccharides have different number average molecular weight characteristics to enable the control of the mechanical features of the sponge.

Sinusitis, enlarged nasal turbinates, tumors, infections, hearing disorders, allergic conditions, facial fractures and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches and, in many cases, flexible catheters as opposed to instruments having rigid shafts. Various diagnostic procedures and devices are used to perform imaging studies, mucus flow studies, air/gas flow studies, anatomic dimension studies, endoscopic studies and transillumination studies. Access and occluder devices may be used to establish fluid tight seals in the anterior or posterior nasal cavities/nasopharynx and to facilitate insertion of working devices (e.g., scopes, guidewires, catheters, tissue cutting or remodeling devices, electrosurgical devices, energy emitting devices, devices for injecting diagnostic or therapeutic agents, devices for implanting devices such as stents, substance eluting devices, substance delivery implants, etc.

An inflatable device for insertion into a user's nose for controlling nasal exudation has an elongated shaft including at least one lumen for accommodating a fluid; an inflatable balloon connected to the shaft, the balloon being in fluid connection to the lumen; and an absorber for absorbing nasal exudates, the absorber being disposed at an outer circumference of the shaft and/or at a distal tip portion of the device. Another inflatable device for insertion into a user's nose for controlling nasal exudation has an elongated shaft including at least one lumen for accommodating a fluid; and an inflatable balloon connected to the shaft, the balloon being in fluid connection to the lumen; the balloon containing a cooling agent, wherein the cooling agent is configured to cool the balloon when coming into contact with the fluid.

The claimed method relates to a method for reducing blood loss. More specifically, the claimed method utilizes at least one compound deposited within and/or on a medical applicator to reduce blood loss experienced by a user. In some embodiments, the method may include depositing at least one compound onto or within a medical applicator which promotes diminished blood flow and coagulation when the applicator is used. More specifically, the medical applicator may have a compound adhered to the surface which acts as a catalyst to instigate blood clotting when the medical applicator is used for its intended purpose. In some embodiments, an antifibrinolytic may be deposited onto the medical applicator. In other embodiments, compounds causing vasoconstriction may be deposited onto the medical applicator. In yet other embodiments, a plurality of compounds may be deposited within and/or on the surface of the medical applicator.

An implantable article comprising a dissolvable sponge derived from the mixture of chitosan, a first polysaccharide and a second polysaccharides. The polysaccharides have different number average molecular weight characteristics to enable the control of the mechanical features of the sponge.

Sinusitis, enlarged nasal turbinates, tumors, infections, hearing disorders, allergic conditions, facial fractures and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches and, in many cases, flexible catheters as opposed to instruments having rigid shafts. Various diagnostic procedures and devices are used to perform imaging studies, mucus flow studies, air/gas flow studies, anatomic dimension studies, endoscopic studies and transillumination studies. Access and occluder devices may be used to establish fluid tight seals in the anterior or posterior nasal cavities/nasopharynx and to facilitate insertion of working devices (e.g., scopes, guidewires, catheters, tissue cutting or remodeling devices, electrosurgical devices, energy emitting devices, devices for injecting diagnostic or therapeutic agents, devices for implanting devices such as stents, substance eluting devices, substance delivery implants, etc.